Le Scouarnec, Lisa
Bouteloup, Vincent
van der Veere, Pieter J
van der Flier, Wiesje M
Teunissen, Charlotte E
Verberk, Inge M W
Planche, Vincent
Chêne, Geneviève
Dufouil, Carole
Article History
Received: 26 July 2024
Accepted: 2 October 2024
First Online: 11 October 2024
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki. All participants provided written informed consent. The MEMENTO cohort protocol was approved by the local ethics committee (“Comité de Protection des Personnes Sud-Ouest et Outre Mer III”; approval number 2010-A01394-35) and was registered on 16 August 2013 in ClinicalTrials.gov (Identifier: NCT01926249).
: Not applicable.
: During the past three years, VP was a local unpaid investigator or sub-investigator for clinical trials granted by NovoNordisk, Biogen, TauRx Pharmaceuticals, Janssen and Alector. He received consultant fees for animal studies from Motac Neuroscience Ltd.All other authors declare no competing interests.
: All other authors declare no competing interests.